JUL 10, 2018 11:15 PM PDT

TdT Positive Cells - Not Just for Neoplasms

WRITTEN BY: Mauri Brueggeman

Terminal deoxyncleotidyl transferase (TdT) is a unique DNA polymerase molecule that is expressed by immature lymphoid cells, both normal and mutagenic.  As a cell ages, it loses the TdT expression capability.  Young lymph progenitor cells would be expected then to have this cell marker; cancerous lymph cells can be mutated versions of those young lymph progenitor cells growing out of control so increased TdT levels could be expected, and in fact have been used diagnostically in laboratory medicine.  TdT has been an identifiable marker since the late 1980s where it was found to be enhanced in acute undifferentiated leukemias, immature acute lymphoblastic leukemias, and in a fraction of cases of leukemic patients in blast crisis.  TdT acts by catalyzing the reaction that leads to the addition of deoxynucleotides to hydroxyl ends of oligonucleotides as part of DNA synthesis.  It also contributes to differences in antibody recognition sites by rearrangement of immunoglobulins or T-cell receptors.  It has long been associated with very undifferentiated neoplasms.

A new article published in the journal Human Pathology is a reminder that healthy lymph nodes and lymph cells can also express TdT because they are early lymphoid precursors; this is especially true in pediatric lymph nodes.  There are benign TdT positive lymph nodes in pediatric patients and this group focused on characterizing the presence of benign TdT positive cells and characterize the typical phenotype associated with their presence. 

Findings included that TdT was sparsely positive in all pediatric cases and in more than three quarters of adult lymph nodes evaluated (n=141).  It was noted that there was increased density of TdT positive cells in pediatric lymph nodes and TdT presence was not found to be associated with any clinical or histological factor other than identifying that these were lymphoid precursors with CD34 and CD10 also being expressed.

The study serves as a reminder to be mindful of the common phenotype of TdT positivity in early healthy lymphoid precursors and to carefully avoid misidentification of these cells as early neoplasm markers.

Sources: Human Pathology, International Journal of Biological Markers, American Journal of Clinical Pathology, Pathology Outlines,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAR 19, 2020
Cancer
MAR 19, 2020
Declining death rates for melanoma
Fewer people are dying from melanoma in the United States, suggests new research from the Perlmutter Cancer Center at NY ...
APR 01, 2020
Cancer
APR 01, 2020
New immunotherapy for ovarian cancer
Research published recently in the Journal of Experimental Medicine suggests that targeting macrophages in a new kind of ...
APR 08, 2020
Cancer
APR 08, 2020
Changing cell pH to block pancreatic cancer
New research published in Cancer Discovery suggests that manipulating the pH of pancreatic cancer cells can deter cell g ...
APR 12, 2020
Cancer
APR 12, 2020
Understanding the link between obesity and breast cancer
A researcher from the James Graham Brown Cancer Center at the University of Louisville claims to have figured out the mo ...
APR 30, 2020
Cancer
APR 30, 2020
A New microRNA for the Cancer Fighting Toolkit
MiRNAs are small snippets of genetic information that regulate gene expression thought to be able to regulate up to 60% ...
MAY 26, 2020
Cancer
MAY 26, 2020
Does having a child with cancer increase parents' risk of divorce?
A study from Denmark published in the American Cancer Society journal CANCER reports that having a child with cancer doe ...
Loading Comments...